[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Blood Clotting Factor VIII Market Report 2021

August 2016 | 103 pages | ID: U54EAA35442EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Blood Clotting Factor VIII

Revenue, means the sales value of Blood Clotting Factor VIII

This report studies sales (consumption) of Blood Clotting Factor VIII in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Amgen
  • AstraZeneca
  • Baxter
  • Britannia
  • Capricor
  • CSL Behring
  • GlaxoSmithKline
  • Grifols
  • Ferring
  • Janssen
  • NeuroDerm
  • Octapharma
  • Roche
  • Rhythm Metabolic
  • scPharmceuticals
  • SteadyMed
  • Takeda
  • United Therapeutics
  • UCB
  • US Worldmeds
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Blood Clotting Factor VIII in each application, can be divided into
  • Medical care
  • Hospital
  • Application 3
United States Blood Clotting Factor VIII Market Report 2021

1 BLOOD CLOTTING FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Blood Clotting Factor VIII
1.2 Classification of Blood Clotting Factor VIII
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Blood Clotting Factor VIII
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 USA Market Size (Value and Volume) of Blood Clotting Factor VIII (2011-2021)
  1.4.1 USA Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
  1.4.2 USA Blood Clotting Factor VIII Sales and Growth Rate (2011-2021)
  1.4.3 USA Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)

2 USA BLOOD CLOTTING FACTOR VIII COMPETITION BY MANUFACTURERS

2.1 USA Blood Clotting Factor VIII Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Blood Clotting Factor VIII Revenue and Share by Manufactures (2015 and 2016)

3 USA BLOOD CLOTTING FACTOR VIII (VOLUME AND VALUE) BY TYPE

3.1 USA Blood Clotting Factor VIII Sales and Market Share by Type (2011-2021)
3.2 USA Blood Clotting Factor VIII Revenue and Market Share by Type (2011-2021)

4 USA BLOOD CLOTTING FACTOR VIII (VOLUME) BY APPLICATION

5 USA BLOOD CLOTTING FACTOR VIII MANUFACTURERS ANALYSIS

5.1 Amgen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Blood Clotting Factor VIII Product Type and Technology
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Blood Clotting Factor VIII Sales, Revenue, Price of Amgen (2015 and 2016)
5.2 AstraZeneca
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pharmaceuticals Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.3 Baxter
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Baxter Product Type and Technology
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Baxter Sales, Revenue, Price of Baxter (2015 and 2016)
5.4 Britannia
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Ferring Product Type and Technology
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Britannia Sales, Revenue, Price of Britannia (2015 and 2016)
5.5 Capricor
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Capricor Product Type and Technology
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Capricor Sales, Revenue, Price of Capricor (2015 and 2016)
5.6 CSL Behring
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 CSL Behring Product Type and Technology
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 CSL Behring Sales, Revenue, Price of CSL Behring (2015 and 2016)
5.7 GlaxoSmithKline
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 GlaxoSmithKline Product Type and Technology
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.8 Grifols
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Grifols Product Type and Technology
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Grifols Sales, Revenue, Price of Grifols (2015 and 2016)
5.9 Ferring
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Ferring Product Type and Technology
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Ferring Sales, Revenue, Price of Ferring (2015 and 2016)
5.10 Janssen
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Janssen Product Type and Technology
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Janssen Sales, Revenue, Price of Janssen (2015 and 2016)
5.11 NeuroDerm
5.12 Octapharma
5.13 Roche
5.14 Rhythm Metabolic
5.15 scPharmceuticals
5.16 SteadyMed
5.17 Takeda
5.18 United Therapeutics
5.19 UCB
5.20 US Worldmeds

6 BLOOD CLOTTING FACTOR VIII TECHNOLOGY AND DEVELOPMENT TREND

6.1 Blood Clotting Factor VIII Technology Analysis
6.2 Blood Clotting Factor VIII Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Blood Clotting Factor VIII
Table Classification of Blood Clotting Factor VIII
Figure USA Sales Market Share of Blood Clotting Factor VIII by Type in 2015
Table Applications of Blood Clotting Factor VIII
Figure USA Sales Market Share of Blood Clotting Factor VIII by Application in 2015
Figure Medical care Examples
Figure Hospital Examples
Table USA Blood Clotting Factor VIII Sales, Revenue and Price (2011-2021)
Figure USA Blood Clotting Factor VIII Sales and Growth Rate (2011-2021)
Figure USA Blood Clotting Factor VIII Revenue and Growth Rate (2011-2021)
Table USA Blood Clotting Factor VIII Sales of Key Manufacturers (2015 and 2016)
Table USA Blood Clotting Factor VIII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Blood Clotting Factor VIII Sales Share by Manufacturers
Figure 2016 Blood Clotting Factor VIII Sales Share by Manufacturers
Table USA Blood Clotting Factor VIII Revenue by Manufacturers (2015 and 2016)
Table USA Blood Clotting Factor VIII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Blood Clotting Factor VIII Revenue Share by Manufacturers
Table 2016 USA Blood Clotting Factor VIII Revenue Share by Manufacturers
Table USA Blood Clotting Factor VIII Sales and Market Share by Type (2011-2021)
Table USA Blood Clotting Factor VIII Sales Share by Type (2011-2021)
Figure Sales Market Share of Blood Clotting Factor VIII by Type (2011-2021)
Figure USA Blood Clotting Factor VIII Sales Growth Rate by Type (2011-2021)
Table USA Blood Clotting Factor VIII Revenue and Market Share by Type (2011-2021)
Table USA Blood Clotting Factor VIII Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Blood Clotting Factor VIII by Type (2011-2021)
Figure USA Blood Clotting Factor VIII Revenue Growth Rate by Type (2011-2021)
Table USA Blood Clotting Factor VIII Sales and Market Share by Application (2011-2021)
Table USA Blood Clotting Factor VIII Sales Share by Application (2011-2021)
Figure Sales Market Share of Blood Clotting Factor VIII by Application (2011-2021)
Figure USA Blood Clotting Factor VIII Sales Growth Rate by Application (2011-2021)
Table Amgen Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Blood Clotting Factor VIII Sales, Revenue, Price of US Worldmeds (2015 and 2016)


More Publications